![Paul B. Knight](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul B. Knight
Direktor/Vorstandsmitglied bei Molecular Diagnostics & Therapeutics, Inc.
Profil
Paul B.
Knight has been a Director of Molecular Diagnostics & Therapeutics, Inc. since August 2000.
He is President of Transwestern Financial Advisors.
Mr. Knight has experience in capital management, financial forecasting, preparation of financial statements, and overseeing SEC filings and requirements
Aktive Positionen von Paul B. Knight
Unternehmen | Position | Beginn |
---|---|---|
Molecular Diagnostics & Therapeutics, Inc.
![]() Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Direktor/Vorstandsmitglied | 01.08.2000 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Molecular Diagnostics & Therapeutics, Inc.
![]() Molecular Diagnostics & Therapeutics, Inc. Medical SpecialtiesHealth Technology Molecular Diagnostics & Therapeutics, Inc. manufactures and distributes nuclear medicines. Its products include sodium iodide, palladium, thallium, thallous chloride, technetium and pet products. The company on February 19, 1992 and is headquartered in Longmont, CO. | Health Technology |